HemoShear Revenue and Competitors
Estimated Revenue & Valuation
- HemoShear's estimated annual revenue is currently $11.2M per year.
- HemoShear's estimated revenue per employee is $318,857
- HemoShear's total funding is $60.1M.
Employee Data
- HemoShear has 35 Employees.
- HemoShear grew their employee count by -51% last year.
HemoShear Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $2.7M | 35 | 46% | N/A | N/A |
#2 | $1.4M | 9 | -10% | N/A | N/A |
#3 | $4.3M | 28 | 4% | N/A | N/A |
#4 | $29.3M | 189 | 6% | N/A | N/A |
#5 | $1.1M | 7 | 0% | N/A | N/A |
#6 | $3.5M | 45 | -52% | $56.5M | N/A |
#7 | $0.3M | 2 | 0% | N/A | N/A |
#8 | $4.5M | 29 | 21% | N/A | N/A |
#9 | $1.9M | 12 | 9% | N/A | N/A |
#10 | $2.9M | 37 | 19% | N/A | N/A |
What Is HemoShear?
HemoShear LLC is a biotechnology research company that combines its scientific expertise with its proprietary platform technology in research collaborations with pharmaceutical companies to accelerate drug discovery and development. HemoShear has expertise in the areas of human and animal biology, bioinformatics and molecular profiling for target identification and validation, cell-signaling pathway analysis, sophisticated methods to quantify target genes and proteins, assessment of molecular pharmacology, and methods to determine mechanisms of action for drug efficacy and safety. HemoShear's technology platform can be adapted to replicate the biology of human or animal organ systems in both healthy and disease-prone states by applying physiologically accurate hemodynamic forces to primary cell cultures. HemoShear is currently collaborating with several large pharmaceutical companies on programs that span the drug discovery and development spectrum. HemoShear is a privately held company located in Charlottesville, Virginia. To learn more about HemoShear, visit www.hemoshear.com.
keywords:Biotechnology
$60.1M
Total Funding
35
Number of Employees
$11.2M
Revenue (est)
-51%
Employee Growth %
N/A
Valuation
N/A
Accelerator
HemoShear's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Interim CEO | Reveal Email/Phone |
2 | Accounting/HR Coordinator | Reveal Email/Phone |
3 | Executive Director, Head Discovery Biology | Reveal Email/Phone |
4 | Principal Scientist | Reveal Email/Phone |
5 | Cell Culture Coordinator | Reveal Email/Phone |
6 | Research Scientist | Reveal Email/Phone |
7 | Laboratory Operations Coordinator | Reveal Email/Phone |
8 | Director, Computational Biology | Reveal Email/Phone |
9 | Scientist I | Reveal Email/Phone |
10 | Chief Financial Officer | Reveal Email/Phone |
HemoShear News
CHARLOTTESVILLE, Va., July 22, 2021 /PRNewswire/ -- HemoShear Therapeutics, Inc., a clinical stage company developing treatments for rare metabolic disorders, today announced that the first two patients have been dosed in the HERO (HElp Reduce Organic Acids) Phase 2 clinical trial of HST5040, ...
HemoShear Therapeutics, Inc., a Charlottesville, Va.-based clinical stage company developing treatments for rare metabolic disorders, has raised $40m in Series A financing. The round was led by Suvretta Capital with participation from Janus Henderson Investors, Adage Capital Management LP and o ...
HemoShear Therapeutics, Inc., a Charlottesville, Va.-based clinical stage company developing treatments for rare metabolic disorders, has raised $40m in Series A financing. The round was led by Suvretta Capital with participation from Janus Henderson Investors, Adage Capital Management LP and o ...
Other Companies in Charlottesville
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $2.7M | 35 | 46% | N/A |
#2 | $3.9M | 35 | 6% | N/A |
#3 | $5M | 35 | -3% | N/A |
#4 | N/A | 35 | 35% | N/A |
#5 | $5M | 35 | 3% | N/A |